The hepatic suppression of FOXO1 and FOXO3 causes hypoglycemia and hyperlipidemia in FOXO1 and FOXO3 knockout mice; moreover, the expression of hepatic FOXOs affects the reduction of gluconeogenic gene expression and insulin resistance35. Here, INS is linked to hyperlipidemia.